Neal Fowler is the founder of Pathalys Pharma. Pathalys Pharma has raised $105M in total funding. Latest round: Series B. Based in Research Triangle Park, NC.
Neal Fowler is the CEO of Pathalys Pharma, a late-stage biopharmaceutical company dedicated to developing treatments for chronic kidney disease (CKD). He has been CEO since the company's inception in January 2022. Pathalys Pharma initiated operations with seed funding from DaVita Venture Group and Catalys Pacific.
Full founder directory · Investor directory · Company funding database · Fundraising library